December 20, 2019
American Health Line rounds up the latest health care news in the states.
December 19, 2019
HHS on Wednesday issued a notice of proposed rulemaking and draft guidance that together would allow states and drugmakers to import lower-cost versions of prescription drugs from other countries—though the proposals exclude certain high-cost and specialty drugs, such as biologics and insulin, that have been major concerns in discussions about U.S. drug pricing.
December 17, 2019
Congressional negotiators on Monday released a nearly $1.4 trillion spending agreement that would fund the federal government, including health agencies, through the end of fiscal year 2020 and includes several health care provisions—such as measures to permanently repeal three Affordable Care Act taxes, delay cuts to Medicaid disproportionate-share hospital payments, raise the minimum tobacco purchasing age, and more.
December 16, 2019
Glassdoor on Wednesday released its annual Employees' Choice Awards for the Best Places to Work in 2020, and 21 health care and health care-adjacent organizations were recognized.
December 13, 2019
The House on Thursday voted 230-291 to pass House Speaker Nancy Pelosi's (D-Calif.) bill intended to lower prescription drug prices in the United States, and voted 201-223 to reject a bill introduced by House Republicans that was intended to serve as an alternative to Pelosi's measure.
December 10, 2019
Leaders on the Senate Finance Committee on Friday unveiled a new, bipartisan bill intended to lower prescription drug prices, and House Republicans on Monday announced a similar bill—both of which clash with a separate proposal introduced earlier this year by House Speaker Nancy Pelosi (D-Calif.).
December 6, 2019
Forbes this week released its annual "30 Under 30 in Healthcare" list, which includes biological researchers, entrepreneurs, physicians, and PhD students under 30 years of age who are "tackling health care issues at every scale."
December 2, 2019
Early research supports the theory that humans age as a result of primeval genetic mechanisms intended to regulate and repair our aging cells, but there might be ways to "turn off" these mechanisms to slow or even reverse aging, according to David Sinclair, a professor of genetics at Harvard Medical School, and Matthew LaPlante, an associate professor of journalism at Utah State University.
November 21, 2019
Stephen Hahn, President Trump's nominee for FDA commissioner, on Wednesday faced questions from lawmakers on the Senate Health, Education, Labor and Pensions Committee regarding drug shortages and prices, e-cigarette use, and more.
Two patients with different blood diseases who were treated with CRISPR in the summer are showing significant improvements, according to new data released Tuesday.
Advisory Board. All rights reserved.